Sue Bailey, chair of the child and adolescent faculty of the Royal College of Psychiatrists, said findings from the US Food and Drug Administration had caused "great concern and anxiety among parents, young people and in child psychiatrists" and were "making us relook at our whole approach to paediatric prescribing, which may be a good thing".
A spokeswoman for the Department of Health said the UK Medicines and Healthcare Products Regulatory Authority was reviewing whether current advice needed to be changed.
Prozac was singled out by the authority as the only antidepressant doctors can prescribe to children in Britain after other drugs from the selective serotonin uptake inhibitor family were banned for use in children.
Register Now to Continue Reading
Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:
What's Included
-
Free access to 4 subscriber-only articles per month
-
Email newsletter providing advice and guidance across the sector
Already have an account? Sign in here
